Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Pandemic influenza vaccine
BIOLOGICAL
4 trials
Sponsors
Seqirus
, Novartis
, Altimmune, Inc.
Conditions
Influenza
Influenza A Subtype H5N1 Infection
Phase 1
Study of a Pandemic Influenza Vaccine
Completed
NCT00136331
Seqirus
Influenza
Start: 2005-10-31
End: 2006-11-30
Target: 400
Updated: 2016-07-19
Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.
Completed
NCT00755703
Altimmune, Inc.
Influenza A Subtype H5N1 Infection
Start: 2008-10-31
End: 2011-12-31
Updated: 2025-05-29
Phase 2
Phase II Study of Pandemic Influenza Vaccine
Completed
NCT00320346
Seqirus
Influenza
Start: 2006-07-31
End: 2006-09-30
Target: 400
Updated: 2016-07-19
Phase 3
Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects
Completed
NCT00434733
Novartis
Influenza
Start: 2007-01-31
Target: 4400
Updated: 2008-04-24
Related Papers
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.
2008-06-13
63 citations